BriaCell Therapeutics Corp. (BCTX) vs Edesa Biotech, Inc. (EDSA)
A side-by-side comparison of BriaCell Therapeutics Corp. and Edesa Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCTX
BriaCell Therapeutics Corp.
$4.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
EDSA
Edesa Biotech, Inc.
$3.72HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BCTX vs EDSA
growth of $100 · dividends reinvested · last 10yBCTX -99.9% (-53.1%/yr)EDSA -99.4% (-40.3%/yr)EDSA compounded faster over this window
Log scale — wide-divergence pair
BCTX EDSA
BCTX vs EDSA: by the numbers
- •EDSA is the larger company ($36M vs $35M market cap).
Metrics side by side
Valuation
| Metric | BCTX | EDSA |
|---|---|---|
| P/B ratio | 1.45 | 89.82 |
Profitability
| Metric | BCTX | EDSA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -154.06% | -160.05% |
| ROIC | -164.58% | -166.02% |
Growth (annualized)
| Metric | BCTX | EDSA |
|---|---|---|
| Total return CAGR (5Y) | -67.32% | -39.88% |
Frequently asked
- How have BCTX and EDSA total returns compared?
- Over the past 10 years, BCTX delivered -52.81% and EDSA delivered -40.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.